Serum ‘central nervous system specific’ protein biomarkers of traumatic brain injury

References

• 1. Teasdale G , Jennett B . Assessment of coma and impaired consciousness. A practical scale . Lancet 2 ( 7872 ), 81 – 84 ( 1974 ).
  Medline CASGoogle Scholar
• 2. Rifai N , Gillette MA , Carr SA . Protein biomarker discovery and validation: the long and uncertain path to clinical utility . Nat. Biotechnol. 24 ( 8 ), 971 – 983 ( 2006 ).
  Medline CASGoogle Scholar
• 3. Anderson NL , Anderson NG . The human plasma proteome: history, character, and diagnostic prospects . Mol. Cell. Proteomics 1 ( 11 ), 845 – 867 ( 2002 ).
  Medline CASGoogle Scholar
• 4. Mondello S , Muller U , Jeromin A , Streeter J , Hayes RL , Wang KK . Blood-based diagnostics of traumatic brain injuries . Expert Rev. Mol. Diagn. 11 ( 1 ), 65 – 78 ( 2011 ).
  MedlineGoogle Scholar
• 5. Agoston DV , Elsayed M . Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder . Front Neurol. 3 , 107 ( 2012 ).
  Medline CASGoogle Scholar
• 6. Royds JA , Davies-Jones GA , Lewtas NA , Timperley WR , Taylor CB . Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system . J. Neurol. Neurosurg. Psychiatry 46 ( 11 ), 1031 – 1036 ( 1983 ).
  Medline CASGoogle Scholar
• 7. Bohmer AE , Oses JP , Schmidt AP et al. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury . Neurosurgery 68 ( 6 ), 1624 – 1630 ; discussion 1630–1621 ( 2011 ).
  MedlineGoogle Scholar
• 8. Chiaretti A , Barone G , Riccardi R et al. NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children . Neurology 72 ( 7 ), 609 – 616 ( 2009 ).
  Medline CASGoogle Scholar
• 9. Varma S , Janesko KL , Wisniewski SR et al. F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children . J. Neurotrauma 20 ( 8 ), 781 – 786 ( 2003 ).
  MedlineGoogle Scholar
• 10. Berger RP , Pierce MC , Wisniewski SR et al. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children . Pediatrics 109 ( 2 ), E31 ( 2002 ).
  MedlineGoogle Scholar
• 11. Ross SA , Cunningham RT , Johnston CF , Rowlands BJ . Neuron-specific enolase as an aid to outcome prediction in head injury . Br. J. Neurosurg. 10 ( 5 ), 471 – 476 ( 1996 ).
  Medline CASGoogle Scholar
• 12. Zetterberg H , Smith DH , Blennow K . Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood . Nat. Rev. Neurol 9 ( 4 ), 201 – 210 ( 2013 ).
  Medline CASGoogle Scholar
• 13. Day IN , Thompson RJ . UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein . Prog. Neurobiol. 90 ( 3 ), 327 – 362 ( 2010 ).
  Medline CASGoogle Scholar
• 14. Newcomb JK , Kampfl A , Posmantur RM et al. Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat . J. Neurotrauma 14 ( 6 ), 369 – 383 ( 1997 ).
  Medline CASGoogle Scholar
• 15. Pike BR , Flint J , Dutta S , Johnson E , Wang KK , Hayes RL . Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats . J. Neurochem. 78 ( 6 ), 1297 – 1306 ( 2001 ).
  Medline CASGoogle Scholar
• 16. Ballatore C , Lee VM , Trojanowski JQ . Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders . Nat. Rev. Neurosci. 8 ( 9 ), 663 – 672 ( 2007 ).
  Medline CASGoogle Scholar
• 17. Zimmer DB , Cornwall EH , Landar A , Song W . The S100 protein family: history, function, and expression . Brain Res. Bull. 37 ( 4 ), 417 – 429 ( 1995 ).
  Medline CASGoogle Scholar
• 18. Sorci G , Bianchi R , Riuzzi F et al. S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond . Cardiovasc. Psychiatry Neurol. 2010 , ( 2010 ).
  MedlineGoogle Scholar
• 19. Yardan T , Erenler AK , Baydin A , Aydin K , Cokluk C . Usefulness of S100B protein in neurological disorders . J. Pak. Med. Assoc. 61 ( 3 ), 276 – 281 ( 2011 ).
  MedlineGoogle Scholar
• 20. Middeldorp J , Hol EM . GFAP in health and disease . Prog. Neurobiol. 93 ( 3 ), 421 – 443 ( 2011 ).
  Medline CASGoogle Scholar
• 21. Haqqani AS , Hutchison JS , Ward R , Stanimirovic DB . Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS . J. Neurotrauma 24 ( 1 ), 54 – 74 ( 2007 ).
  MedlineGoogle Scholar
• 22. Boggs JM . Myelin basic protein: a multifunctional protein . Cellular Mol. Life Sci. 63 ( 17 ), 1945 – 1961 ( 2006 ).
  Medline CASGoogle Scholar
• 23. Kimura M , Sato M , Akatsuka A et al. Overexpression of a minor component of myelin basic protein isoform (17.2 kDa) can restore myelinogenesis in transgenic shiverer mice . Brain Res. 785 ( 2 ), 245 – 252 ( 1998 ).
  Medline CASGoogle Scholar
• 24. Nakajima K , Ikenaka K , Kagawa T et al. Novel isoforms of mouse myelin basic protein predominantly expressed in embryonic stage . J. Neurochem. 60 ( 4 ), 1554 – 1563 ( 1993 ).
  Medline CASGoogle Scholar
• 25. Ottens AK , Golden EC , Bustamante L , Hayes RL , Denslow ND , Wang KK . Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry . J. Neurochem. 104 ( 5 ), 1404 – 1414 ( 2008 ).
  Medline CASGoogle Scholar
• 26. Givogri MI , Bongarzone ER , Campagnoni AT . New insights on the biology of myelin basic protein gene: the neural-immune connection . J. Neurosci. Res. 59 ( 2 ), 153 – 159 ( 2000 ).
  Medline CASGoogle Scholar
• 27. Akiyama K , Ichinose S , Omori A , Sakurai Y , Asou H . Study of expression of myelin basic proteins (MBPs) in developing rat brain using a novel antibody reacting with four major isoforms of MBP . J. Neurosci. Res. 68 ( 1 ), 19 – 28 ( 2002 ).
  Medline CASGoogle Scholar
• 28. Boggs JM , Yip PM , Rangaraj G , Jo E . Effect of posttranslational modifications to myelin basic protein on its ability to aggregate acidic lipid vesicles . Biochemistry (Mosc.) 36 ( 16 ), 5065 – 5071 ( 1997 ).
  Medline CASGoogle Scholar
• 29. Berger RP , Hayes RL , Richichi R , Beers SR , Wang KK . Serum concentrations of ubiquitin C-terminal hydrolase-L1 and alphaII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI . J. Neurotrauma 29 ( 1 ), 162 – 167 ( 2012 ).
  MedlineGoogle Scholar
• 30. Diaz-Arrastia R , Wang KK , Papa L et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) . J. Neurotrauma doi:10.1089/neu.2013.3040 ( 2013 ) ( Epub ahead of print ).
  Google Scholar
• 31. Feala JD , Abdulhameed MD , Yu C et al. Systems biology approaches for discovering biomarkers for traumatic brain injury . J. Neurotrauma 30 ( 13 ), 1101 – 1116 ( 2013 ).
  MedlineGoogle Scholar
• 32. Papa L , Lewis LM , Silvestri S et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention . J. Trauma Acute Care Surg. 72 ( 5 ), 1335 – 1344 ( 2012 ).
  MedlineGoogle Scholar
• 33. Honda M , Tsuruta R , Kaneko T et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase . J. Trauma 69 ( 1 ), 104 – 109 ( 2010 ).
  Medline CASGoogle Scholar
• 34. Berger RP , Adelson PD , Pierce MC , Dulani T , Cassidy LD , Kochanek PM . Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children . J. Neurosurg. 103 ( 1 Suppl ), 61 – 68 ( 2005 ).
  MedlineGoogle Scholar
• 35. Haskins WE , Kobeissy FH , Wolper RA et al. Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry . J. Neurotrauma 22 ( 6 ), 629 – 644 ( 2005 ).
  MedlineGoogle Scholar
• 36. Kobeissy FH , Ottens AK , Zhang Z et al. Novel differential neuroproteomics analysis of traumatic brain injury in rats . Mol. Cell. Proteomics 5 ( 10 ), 1887 – 1898 ( 2006 ).
  Medline CASGoogle Scholar
• 37. Ottens AK , Kobeissy FH , Wolper RA et al. A multidimensional differential proteomic platform using dual-phase ion-exchange chromatography-polyacrylamide gel electrophoresis/reversed-phase liquid chromatography tandem mass spectrometry . Anal. Chem. 77 ( 15 ), 4836 – 4845 ( 2005 ).
  Medline CASGoogle Scholar
• 38. Raphael I , Mahesula S , Kalsaria K et al. Microwave and magnetic (M(2)) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis . Electrophoresis 33 ( 24 ), 3810 – 3819 ( 2012 ).
  Medline CASGoogle Scholar
• 39. Mahesula S , Raphael I , Raghunathan R et al. Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis . Electrophoresis 33 ( 24 ), 3820 – 3829 ( 2012 ).
  Medline CASGoogle Scholar
• 40. Cortes DF , Landis MK , Ottens AK . High-capacity peptide-centric platform to decode the proteomic response to brain injury . Electrophoresis 33 ( 24 ), 3712 – 3719 ( 2012 ).
  Medline CASGoogle Scholar
• 41. Mercier E , Boutin A , Lauzier F et al. Predictive value of S-100beta protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis . BMJ 346 , f1757 ( 2013 ).
  MedlineGoogle Scholar
• 42. Rodriguez-Rodriguez A , Egea-Guerrero JJ , Leon-Justel A et al. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults . Clin. Chim. Acta 414 , 228 – 233 ( 2012 ).
  Medline CASGoogle Scholar
• 43. Morochovic R , Racz O , Kitka M et al. Serum S100B protein in early management of patients after mild traumatic brain injury . Eur. J. Neurol. 16 ( 10 ), 1112 – 1117 ( 2009 ).
  Medline CASGoogle Scholar
• 44. Spinella PC , Dominguez T , Drott HR et al. S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury . Crit. Care Med. 31 ( 3 ), 939 – 945 ( 2003 ).
  Medline CASGoogle Scholar
• 45. Korfias S , Stranjalis G , Boviatsis E et al. Serum S-100B protein monitoring in patients with severe traumatic brain injury . Intensive Care Med. 33 ( 2 ), 255 – 260 ( 2007 ).
  Medline CASGoogle Scholar
• 46. Mondello S , Linnet A , Buki A et al. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury . Neurosurgery 70 ( 3 ), 666 – 675 ( 2012 ).
  MedlineGoogle Scholar
• 47. Brophy GM , Mondello S , Papa L et al. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids . J. Neurotrauma 28 ( 6 ), 861 – 870 ( 2011 ).
  MedlineGoogle Scholar
• 48. Papa L , Lewis LM , Falk JL et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention . Ann. Emerg. Med. 59 ( 6 ), 471 – 483 ( 2012 ).
  MedlineGoogle Scholar
• 49. Fraser DD , Close TE , Rose KL et al. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum . Pediatr. Crit. Care Med. 12 ( 3 ), 319 – 324 ( 2011 ).
  MedlineGoogle Scholar
• 50. Pelinka LE , Kroepfl A , Schmidhammer R et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma . J. Trauma 57 ( 5 ), 1006 – 1012 ( 2004 ).
  Medline CASGoogle Scholar
• 51. Bulut M , Koksal O , Dogan S et al. Tau protein as a serum marker of brain damage in mild traumatic brain injury: preliminary results . Adv. Ther. 23 ( 1 ), 12 – 22 ( 2006 ).
  Medline CASGoogle Scholar
• 52. Trojanowski JQ , Schuck T , Schmidt ML , Lee VM . Distribution of tau proteins in the normal human central and peripheral nervous system . J. Histochem. Cytochem. 37 ( 2 ), 209 – 215 ( 1989 ).
  Medline CASGoogle Scholar
• 53. Franz G , Beer R , Kampfl A et al. Amyloid beta 1–42 and tau in cerebrospinal fluid after severe traumatic brain injury . Neurology 60 ( 9 ), 1457 – 1461 ( 2003 ).
  Medline CASGoogle Scholar
• 54. Bell MJ , Kochanek PM . Pediatric traumatic brain injury in 2012: the year with new guidelines and common data elements . Crit. Care Clin. 29 ( 2 ), 223 – 238 ( 2013 ).
  MedlineGoogle Scholar
• 55. Niyonkuru C , Wagner AK , Ozawa H , Amin K , Goyal A , Fabio A . Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical example . J. Neurotrauma 30 ( 11 ), 938 – 945 ( 2013 ).
  MedlineGoogle Scholar